Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page
Provident Healthcare Partners Provident Healthcare Partners

Q2 2024 Ophthalmology Update

Provident Healthcare Partners
Skip to the end of the Expertise Menu

Q2 2024 Ophthalmology Update

The ophthalmology M&A market continued its tepid pace in the second quarter as sizeable transactions have been limited in the year-to-date period. The market has slowed in recent quarters given a lack of practices exploring sale processes coupled with an increased focus from existing platforms on organic growth ahead of exploring sale processes of their own in the next 12 to 18 months.

Although the volume of market activity has slowed, Provident expects the “log jam” to break in the back half of the year given the number of practices that are rumored to be out to market or that are starting to explore their options. Even in the face of some macro headwinds, the market remains particularly seller-friendly for high caliber, scaled practices in good markets with young and expansive physician rosters.

To print and download the full Ophthalmology Update report, please click below…

[holo_button icon=”/wp-content/uploads/2024/07/Q2-2024-Ophthalmology-vF.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]